Targeting the N-Methyl-d-Aspartate Receptor for Chronic Pain Management
- 1 November 2000
- journal article
- review article
- Published by Elsevier BV in Journal of Pain and Symptom Management
- Vol. 20 (5), 358-373
- https://doi.org/10.1016/s0885-3924(00)00213-x
Abstract
No abstract availableKeywords
This publication has 161 references indexed in Scilit:
- Histological Findings After Long-Term Infusion of Intrathecal Ketamine for Chronic Pain: A Case ReportJournal of Pain and Symptom Management, 1999
- Analgesic Effect of Oral Ketamine in Chronic Neuropathic Pain of Spinal Origin: A Case ReportJournal of Pain and Symptom Management, 1999
- Clinical Experience with Oral KetamineJournal of Pain and Symptom Management, 1999
- The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliteransActa Anaesthesiologica Scandinavica, 1998
- Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: Eliprodil, ifenprodil and other native NMDA receptor subtype selective compoundsNeurochemistry International, 1996
- Role of Magnesium Sulfate in Seizure Prevention in Patients with Eclampsia and Pre-EclampsiaDrug Safety, 1996
- Long-term ketamine subcutaneous continuous infusion in neuropathic cancer painJournal of Pain and Symptom Management, 1995
- Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patientJournal of Pain and Symptom Management, 1995
- Glutamatergic drugs in Parkinson's diseaseLife Sciences, 1994
- The involvement of N-methyl-d-aspartate (NMDA) and non-NMDA receptors in the responsiveness of rat spinal neurons with input from the chronically inflamed ankleNeuroscience Letters, 1994